Cationic amphiphilic drug-induced renal cortical lysosomal phospholipidosis: an in vivo comparative study with gentamicin and chlorphentermine.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Toxicology and Applied Pharmacology

• Publication date

  1987-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0041-008X(87)90068-8PMID 3424375
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots

  2007cited by this paper
• Comparative Effects of Aminoglycosides on Renal Cortical and Urinary Phospholipids in the Rat

  1986cited by this paper
• Effect of netilmicin on the phospholipid composition of subcellular fractions of rat renal cortex.

  1985cited by this paper
• Interaction of gentamicin and spermine with bilayer membranes containing negatively charged phospholipids.

  1985cited by this paper
• Gentamicin or chlorphentermine induction of phospholipidosis in the developing organism: role of tissue and species in manifestation of toxicity.

  1985cited by this paper
• Molecular studies of the induction of cellular phospholipidosis by cationic amphiphilic drugs.

  1984cited by this paper
• In vitro inhibition of lysosomal phospholipases by aminoglycoside antibiotics: a comparative study.

  1984cited by this paper
• Effects of aminoglycosides on proximal tubule brush border membrane phosphatidylinositol-specific phospholipase C.

  1984cited by this paper
• Interactions between renal brush border membranes and polyamines.

  1984cited by this paper
• Aminoglycoside-induced functional and biochemical defects in the renal cortex.

  1984cited by this paper
• Pulmonary and generalized lysosomal storage induced by amphiphilic drugs.

  1984cited by this paper
• Renal lysosomal protein digestion in experimental lipidosis

  1983cited by this paper
• S-86451, a New Derivative of Gentamicin With Reduced Nephrotoxicity - Biochemical, Morphological and Functional-studies

  1983cited by this paper
• Aminoglycosides induce a phospholipidosis in the renal cortex of the rat: an early manifestation of nephrotoxicity.

  1982cited by this paper
• Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin.

  1982cited by this paper
• Aminoglycoside antibiotics inhibit lysosomal phospholipase A and C from rat liver in vitro.

  1982cited by this paper
• Alterations in newborn and adult rat lung morphology and phospholipid levels after chlorcyclizine or chlorphentermine treatment.

  1982cited by this paper
• Aminoglycoside inhibition of a renal phosphatidylinositol phospholipase C.

  1982cited by this paper
• Impairment of renal function in rats with generalized lipidosis as induced by chlorphentermine.

  1981cited by this paper
• The effect of phenobarbital on chlorphentermine-induced lipidosis-like alterations in renal tissue of adult and newborn rats

  1981cited by this paper
• Studies on drug-induced lipidosis: subcellular localization of phospholipid and cholesterol in the liver of rats treated with chloroquine or 4,4'-bis (diethylaminoethoxy)alpha, beta-diethyldiphenylethane.

  1980cited by this paper
• Gentamicin-induced nephrotoxicity: a cell biology approach.

  1980cited by this paper
• Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.

  1980cited by this paper
• Lipidosis induced by amphiphilic cationic drugs.

  1978cited by this paper
• Myeloid bodies in the renal tubules of humans: relationship to gentamicin therapy.

  1978cited by this paper
• Lipidosislike renal changes in rats treated with chlorphentermine or with tricyclic antidepressants

  1975cited by this paper
• Isolation of kidney lysosomes.

  1974cited by this paper
• Nephrotoxicity of gentamicin.

  1974cited by this paper
• Possible involvement of cardiac Na+, K+-adenosine triphosphatase in the mechanism of action of cardiac glycosides.

  1969cited by this paper
• Enzymes of plasma membranes of liver.

  1967cited by this paper
• Methods in Enzymology , Vol

  1966cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957cited by this paper
• Microdetermination of Phosphorus

  1956cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane

  2020cites this paper
• Hypomagnesemia in type 2 diabetes: cause or consequence?

  2019cites this paper
• Renal phospholipidosis and impaired magnesium handling in high‐fat‐diet–fed mice

  2019cites this paper
• Drug Induced Phospholipidosis and Cationic Amphiphilic Drugs

  2018cites this paper
• Anti Leishmanial Activities of Some Antidepressant Drugs

  2016cites this paper
• Validation of Replacement of the Synthetic Food Dye 'Sunset Yellow'-Induced Hepatotoxicity and Genotoxicity with the Nutraceutical 'Curcumin' in Mice

  2016cites this paper
• Putative biomarker for phospholipid accumulation in cultured cells treated with phospholipidosis-inducing drugs: alteration of the phosphatidylinositol composition detected using high-performance liquid chromatography-tandem mass spectrometry.

  2014cites this paper
• In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.

  2012cites this paper
• Interspecies Pharmacokinetic Scaling and the Prediction of Human Pharmacokinetics Using Animal and Cell Models

  2012cites this paper
• Identification of Drugs Inducing Phospholipidosis by Novel in vitro Data

  2012cites this paper
• An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin.

  2011cites this paper
• Identificación de biomarcadores urinarios para la mejora del diagnóstico del daño renal agudo inducido por gentamicina

  2010cites this paper
• Sub-nephrotoxic doses of gentamicin predispose animals to developing acute kidney injury and to excrete ganglioside M2 activator protein.

  2010cites this paper
• A Strategy for Risk Management of Drug-Induced Phospholipidosis

  2009cites this paper
• Drug-induced Phospholipidosis : Pathological Aspects and Its Prediction

  2008cites this paper
• Gene expression profiling in rat liver treated with compounds inducing phospholipidosis.

  2008cites this paper
• An Immunohistochemical Approach to Differentiate Hepatic Lipidosis from Hepatic Phospholipidosis in Rats

  2007cites this paper
• Physicochemical and cell-based approach for early screening of phospholipidosis-inducing potential.

  2006cites this paper
• Validation of an in vitro screen for phospholipidosis using a high-content biology platform

  2006cites this paper
• Drug‐induced phospholipidosis

  2006cites this paper
• Modulation of the in vitro activity of lysosomal phospholipase A1 by membrane lipids.

  2005cites this paper
• Effect of spironolactone on cisplatininduced nephrotoxicity in rabbits

  2001cites this paper
• Drug-Induced Phospholipidosis: Are There Functional Consequences?

  2001cites this paper
• Hyperlipidaemia in cisplatin-induced nephrotic rats

  1999cites this paper
• Cationic Amphiphilic Drug-Induced Phospholipidosis

  1997cites this paper
• Cationic lipophilic drugs: mechanisms of action, potential consequences, and reversibility.

  1997cites this paper
• Subcellular Biochemical and Pathological Correlates in Experimental Models of Hepatotoxicity

  1996cites this paper
• Acidification of lysosomes and endosomes.

  1996cites this paper
• Acidification of lysosomes and endosomes.

  1996cites this paper
• Effects of fish oil and sunflower oil supplementations on gentamicin-induced nephrotoxicity in rat

  1995cites this paper
• Urinary phospholipids excretion in neonates treated with amikacin.

  1994cites this paper
• Plasma Lipid Profile in Rats with Gentamicin-Induced Nephrotoxicity

  1993cites this paper
• Perspectives on Intracellular Storage and Transport of Cationic-Lipophilic Drugs

  1993cites this paper
• Amiodarone — induced changes in surfactant phospholipids of rat lung

  1993cites this paper
• Effect of interaction between gentamicin and pyridoxal-5-phosphate on functional and metabolic parameters in kidneys of female Sprague-Dawley rats.

  1992cites this paper
• Alveolar proteinosis and phospholipidoses of the lungs.

  1991cites this paper
• Altered epidermal morphology secondary to lidocaine iontophoresis: in vivo and in vitro studies in porcine skin.

  1990cites this paper
• Pathogenic factors in aminoglycoside-induced nephrotoxicity.

  1990cites this paper
• ‘Pathogenic factors in aminoglycoside-induced nephrotoxicity’ by S. Kacew and M.G. Bergeron

  1990cites this paper
• Ketoconazole-induced hepatic lysosomal phospholipidosis: the effect of concurrent barbiturate treatment.

  1990cites this paper
• Cationic amphiphilic drugs and phospholipid storage disorder.

  1990cites this paper
• Molecular and biochemical mechanisms of chemically induced nephrotoxicity: a review.

  1990cites this paper
• Gentamicin-induced renal metabolic alterations in newborn rat kidney: lack of potentiation by vancomycin.

  1989cites this paper
• Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity.

  1989cites this paper
• Inhibition of gentamicin-induced nephrotoxicity by pyridoxal-5'-phosphate in the rat.

  1989cites this paper
• Amiodarone-induced pulmonary toxicity in rats: biochemical and pharmacological characteristics.

  1989cites this paper